Brought to you by 
GSK may buy minority stake in African pharmaco Aspen
24 Oct 2016
Executive Summary
Several secondary sources have reported that GlaxoSmithKline is in discussions to acquire 10-25% of public South African drug company Aspen Pharmacare. Analysts say that instead of spending cash, GSK would trade some of its assets for the equity stake.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Nutraceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
GSK may buy minority stake in African pharmaco Aspen
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice